Indo Kordsa Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Indo Kordsa Tbk trades at Rp4,550 (market cap 2.01T, 1.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Indo Kordsa Tbk is far larger — about 3.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 1.2K). Which is the better fit depends on your goals.
| BRAM | LABS | |
|---|---|---|
Market Cap | 2.01T | 584.6B |
Volume | 1.2K | 817.3K |
Lot | 12 | 8.17K |
Turnover | 5.46M | 120.01M |
Average Price | 4,551.67 | 146.84 |
Value | 5.46M | 120.01M |
Indicative Equilibrium Price | — | 146 |
Indicative Equilibrium Volume | — | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indo Kordsa Tbk (the Company) was established in 1981 in Jakarta, PT Branta Mulia Tbk was South East Asian’s first tire cord fabric manufacturer. The Branta Mulia Group has since expanded its vertical integration to include the production facilities of nylon 66 and polyester tire yarns used in the manufacture of tire cord fabrics. The company’s production process applies state of the art technologies in its Indonesian and Thailand tire cord fabric plants. PT Branta Mulia Tbk became a publicly listed company in 1990 when its shares were initially listed on the Jakarta and Surabaya Stock Exchanges. All of the company’s issued shares have been de-listed from PT Bursa Efek Surabaya effective from 5 September 1999.
Read more on BRAM →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →